Results 181 to 190 of about 193,589 (341)

Door to Needle Time and its Impact on Successful Thrombolysis

Journal of Rawalpindi Medical College, 2012
Background: To evaluate the Door to needle time and its impact on successful thrombolysis . Methods : In this cross sectional study all patients admitted with Acute Myocardial Infarction (AMI), who were candidates for fibrinolysis, were included ...
Sarfaraz Ali Zahid
doaj  

Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension. Effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics.

, 1989
Richard M. Prewitt, F.H. Shiffman, David H. Greenberg, Robert A. Cook, John Ducas   +4 more
openalex   +1 more source

The effect of intracoronary thrombolysis with streptokinase on myocardial thallium distribution and left ventricular function assessed by blood-pool scintigraphy [PDF]

, 1982
Maarten L. Simoons, William Wijns, K. Balakumaran, Patrick W. Serruys, Marcel van den Brand, P. Fioretti, Johan H. C. Reiber, Pang Lie, Philip Hugenholtz   +8 more
openalex   +1 more source

A study of factors delaying hospital arrival and predictors of mortality in patients presenting to emergency department with stroke: A developing state scenario [PDF]

, 2010
Background: Thrombolytic therapy for acute ischemic stroke has recently become available in India but its success depends on initiating the treatment in the narrow therapeutic time window.
Chandra, Subhash, Khan, Mudassir Azeez, Nagaraja, Vinayak, Sankapithilu, Ganraj Bhat   +3 more
core   +1 more source

Treatment of Coronary Bifurcation Stenoses Using the DK Mini Crush Technique—Analysis of Resources and Technical Success

Catheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2528-2538, October 1, 2025.
ABSTRACT Background The DK‐mini‐Crush (DKMC) technique, an established strategy to treat coronary bifurcation stenoses, is known to be complex, with possible strain on time and resources. Aims To analyze predictors of technical failure as well as time and resourced required for each procedural step of th DKMC technique.
Florian Weidinger, Stephan Achenbach, Johannes Michael Altstidl, Merve Günes‐Altan, Maximilian Moshage, Monique Tröbs, Mohamed Marwan, Luise Gaede   +7 more
wiley   +1 more source

CORONARY THROMBOLYSIS-THE RATIONAL MANAGEMENT OF EVOLVING MYOCARDIAL INFARCTION [PDF]

, 1982
William Ganz
openalex   +1 more source

Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Large Vessel Coronary Artery Disease

Catheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2519-2527, October 1, 2025.
ABSTRACT Background Drug‐coated balloon (DCB) treatment has shown outcomes comparable to drug‐eluting stent (DES) in small vessel coronary disease. However, evidence for its application in large vessel coronary artery disease (CAD) remains limited. Aims This study evaluated the clinical impact of DCB‐based percutaneous coronary intervention (PCI) in ...
Eun‐Seok Shin, Mi Hee Jang, Sunwon Kim, Dong Oh Kang, Ae‐Young Her, Chang‐Bae Sohn   +5 more
wiley   +1 more source

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

, 1988
Anupama Rao, Craig M. Pratt, Andrew Berke, Allan S. Jaffe, Ira S. Ockene, Theodore Schreiber, William R. Bell, Genell L. Knatterud, Thomas Robertson, Michael L. Terrin   +9 more
openalex   +1 more source

Site‐Specific Antithrombotic Therapy: 24‐Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple‐Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus

Catheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2770-2780, October 1, 2025.
ABSTRACT Background DESyne BDS Plus represents a novel triple drug therapy (TRx) applied on a coronary stent platform eluting the antiproliferative drug Sirolimus along with two anticoagulants (Rivaroxaban and Argatroban) to reduce the site‐specific thrombotic risk.
Stefan Verheye, Bert Ferdinande, Johan Bennett, Rodolfo Staico, Seif El‐Jack, Pim A. L. Tonino, Alexandre Abizaid, Ian Buysschaert, Douglas Scott, Madhav Menon, Gerard Wilkins, Dougal McClean, Tomas Kovarnik, Uwe Christians, Antoinette Neylon, Zlatko Mehmedbegovic, Pieter C. Smits, Marie‐Claude Morice, Mark Webster, the DESyne BDS Plus RCT Investigators   +19 more
wiley   +1 more source

Cerebrovascular events and thrombolysis in pulmonary embolism-induced cardiac arrest: a case series and key challenges

BMC Cardiovascular Disorders
Background and purpose Cerebrovascular events during thrombolysis in cardiac arrest (CA) caused by pulmonary embolism (PE) is a life-threatening condition.
Youping Zhang, Shu Peng, Karl Nelson S.Marquez, Xiangning Fu, Bo Ai, Hua Yan, Wei Zhu, Shusheng Li   +7 more
doaj   +1 more source